MESTAG THERAPEUTICS LTD
12466144Research and experimental development on biotechnology
MESTAG THERAPEUTICS LTD
Research and experimental development on biotechnology
Previous Company Names
Contact & Details
Contact
Registered Address
Suites 15 & 16, Science Village Chesterford Research Park Little Chesterford Saffron Walden CB10 1XL England
Full company profile for MESTAG THERAPEUTICS LTD (12466144), an active life sciences and medical technology company based in Saffron Walden, England. Incorporated 17 Feb 2020. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2020–2024)
Cash in Bank
£23.58M
Net Assets
-£31.66M
Total Liabilities
£60.98M
Turnover
N/A
Employees
42
Debt Ratio
208%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 31 Dec Year End | 2023 31 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
Investors (6)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 4 | Apr 2021 | Seed |
| Investor 6 | Apr 2021 | Seed |
| Investor 2 | Aug 2021 | Seed |
See all 6 investors
Sign up to view complete investor information
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Dunn, Charles | Director | British | England | 29 Jun 2023 | Active |
| Rozen, Issi | Director | American | United States | 16 Jul 2021 | Active |
See all 16 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (1)
Johnson & Johnson
Unknown
- Ownership Of Shares 25 To 50 Percent
Sv7 (imf) Gp Llp
Ceased 16 Jul 2021
Group Structure
Group Structure
No group structure identified
Charges
Charges
Properties
Properties
| Address | Tenure | Price Paid | Date Added |
|---|---|---|---|
Suite 15, Science Village Building, Chesterford Park, Little Chesterford, Saffron Walden UTTLESFORD | Leasehold | £129,756 | 1 Oct 2024 |
Suite 16, Science Village Building, Chesterford Park, Little Chesterford, Saffron Walden UTTLESFORD | Leasehold | £131,208 | 1 Oct 2024 |
Suite 2, Science Village Building, Chesterford Park, Little Chesterford, Saffron Walden UTTLESFORD | Leasehold | £131,208 | 1 Oct 2024 |
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 1 Jun 2026 | Capital | Allotment of shares (GBP 4,739.8895) on 12 Mar 2026 | |
| 11 May 2026 | Accounts | Annual accounts made up to 31 Dec 2025 | |
| 24 Mar 2026 | Officers | Appointment of Mr Charles Dunn as director | |
| 19 Mar 2026 | Confirmation Statement | Confirmation statement made on 15 Feb 2026 with updates | |
| 17 Mar 2026 | Officers | Appointment of Mr Charles Dunn as director |
Allotment of shares (GBP 4,739.8895) on 12 Mar 2026
Annual accounts made up to 31 Dec 2025
Appointment of Mr Charles Dunn as director
Confirmation statement made on 15 Feb 2026 with updates
Appointment of Mr Charles Dunn as director
Recent Activity
Latest Activity
Allotment of shares (GBP 4,739.8895) on 12 Mar 2026
1 weeks ago on 1 Jun 2026
Annual accounts made up to 31 Dec 2025
1 months ago on 11 May 2026
Appointment of Mr Charles Dunn as director
2 months ago on 24 Mar 2026
Confirmation statement made on 15 Feb 2026 with updates
2 months ago on 19 Mar 2026
Appointment of Mr Charles Dunn as director
2 months ago on 17 Mar 2026